(주)셀리드

{
  "address": "서울특별시 관악구",
  "ceo_name": "강창율",
  "certificate": [
    {
      "cert_number": "20140106550",
      "changes": "",
      "disclosure_date": "2014-05-30",
      "first_cert_date": "2014-05-30",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-05-30 ~ 2016-05-29"
    },
    {
      "cert_number": "20160300179",
      "changes": "",
      "disclosure_date": "2016-04-21",
      "first_cert_date": "2014-05-30",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2016-05-30 ~ 2018-05-29"
    },
    {
      "cert_number": "20180300262",
      "changes": "",
      "disclosure_date": "2018-04-26",
      "first_cert_date": "2014-05-30",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2018-05-30 ~ 2020-05-29"
    },
    {
      "cert_number": "20200300657",
      "changes": "",
      "disclosure_date": "2020-06-04",
      "first_cert_date": "2014-05-30",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2020-05-30 ~ 2022-05-29"
    },
    {
      "cert_number": "20220713020025",
      "changes": "",
      "disclosure_date": "2022-07-13",
      "first_cert_date": "2014-05-30",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2022-05-30 ~ 2025-05-29"
    },
    {
      "cert_number": "20250717020015",
      "changes": "소재지",
      "disclosure_date": "2025-07-17",
      "first_cert_date": "2014-05-30",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2025-05-30 ~ 2028-05-29"
    }
  ],
  "company_name": "(주)셀리드",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 4865596000,
      "cost_of_sales": 324530000,
      "current_assets": 20977751000,
      "current_liabilities": 20539210000,
      "gross_profit": 155470000,
      "net_income": -22864575000,
      "net_income_bs": -22864575000,
      "non_current_assets": 24879640000,
      "non_current_liabilities": 2879292000,
      "non_operating_expenses": 9061875000,
      "non_operating_income": 1108634000,
      "operating_profit": -14911334000,
      "revenue": 480000000,
      "sga_expenses": 15066804000,
      "total_assets": 45857391000,
      "total_equity": 22438889000,
      "total_liabilities": 23418502000
    },
    "2023": {
      "capital_stock": 6801488000,
      "cost_of_sales": 0,
      "current_assets": 16874030000,
      "current_liabilities": 10324842000,
      "gross_profit": 0,
      "net_income": -11611436000,
      "net_income_bs": -11611436000,
      "non_current_assets": 47048212000,
      "non_current_liabilities": 13102139000,
      "non_operating_expenses": 1780360000,
      "non_operating_income": 2366876000,
      "operating_profit": -12197952000,
      "revenue": 0,
      "sga_expenses": 12197952000,
      "total_assets": 63922242000,
      "total_equity": 40495261000,
      "total_liabilities": 23426981000
    },
    "2024": {
      "capital_stock": 10551489000,
      "cost_of_sales": 3460080000,
      "current_assets": 11449766000,
      "current_liabilities": 4942719000,
      "gross_profit": 705012000,
      "net_income": -12259048000,
      "net_income_bs": -12259048000,
      "non_current_assets": 64636698000,
      "non_current_liabilities": 19940647000,
      "non_operating_expenses": 1378920000,
      "non_operating_income": 1100370000,
      "operating_profit": -11980498000,
      "revenue": 4165092000,
      "sga_expenses": 12685510000,
      "total_assets": 76086464000,
      "total_equity": 51203098000,
      "total_liabilities": 24883366000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "615,073,000",
      "changes": "615,073,000",
      "date": "2019-07-26"
    }
  ],
  "main_products": "항암면역치료백신",
  "phone": "02-3285-****",
  "years": [
    2024,
    2023,
    2022
  ]
}